Your provider may lower the dosage of these treatments to reduce your risk of experiencing hypoglycemia and, in turn, a tirzepatide headache in the first place
These compounding pharmacies are subject to stricter regulations and oversight by the FDA, similarly to traditional drug manufacturers
Patients should never discontinue semaglutide without consulting their healthcare provider, as the medication provides important benefits for diabetes management or weight loss
SGLT2 inhibitors are preferred in people with HF or at high-risk for HF, whereas GLP-1 receptor agonists are favored for those requiring significant weight loss, ASCVD risk reduction, CKD management, or in whom mitigation of metabolic dysfunction-associated steatotic liver disease (MASLD) or steatohepatitis is a clinical priority [84]
Stimulant laxatives should be reserved for occasional use only